688105.SH
Nanjing Vazyme Biotech Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 22.67
+10.42%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 150.53x
- P/E 2027E
- 86.85x
- P/E 2028E
- 53.76x
- P/S forward
- 5.06x
Trailing multiples
Trailing twelve months
- P/E TTM
- -705.46x
- PEG TTM
- —
- Price / book
- 3.25x
- Price / sales
- 8.26x
- Price / cash flow
- 55.67x
Enterprise value
- Enterprise value
- CNY 11.7B
- EV / sales
- 8.30x
- EV / EBITDA
- 96.32x
- EV / EBIT
- -273.17x
- Market cap
- CNY 11.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026